Almaarefa University
The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.

المخرجات

Research outputs

Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.

4 output Results for «Cochrane Library»

ArticleOpen access2026

Efficacy and long-term impact of HPV vaccination strategies: A Scoping review of clinical trials and follow-up studies

Pharmacy Practice · vol. 23 (4) · 1-6

Background: Human papillomavirus (HPV) is a leading cause of cervical cancer and other HPV-related cancers globally. Vaccination against HPV has proven to be a pivotal intervention in reducing the burden of these diseases. However, questions remain regarding long-term efficacy, dosing strategies, and real-world outcomes of HPV vaccines. Objective: We aim to synthesise evidence from randomised controlled trials and long-term follow-up studies on the efficacy, immunogenicity, safety, and real-world impact of HPV vaccines. Methodology: A comprehensive search was conducted in PubMed, Cochrane Library, Embase, Scopus, and Web of Science for studies published in English from 2019 to 2024. Eligible studies included randomised controlled trials and long-term follow-up analyses focusing on HPV vaccine efficacy, dosing regimens, and population-specific outcomes. Data were extracted and synthesised narratively, with findings organised into five thematic areas. Results: Seventeen studies met the inclusion criteria. Findings confirm the high efficacy of HPV vaccines in preventing HPV-related cancers and precancers, with durable immunogenicity observed up to 12 years post-vaccination. Evidence supports the potential of single-dose regimens, which could improve accessibility in resource-limited settings. Real-world data demonstrated significant reductions in HPV-related diseases across diverse populations, reinforcing the global impact of HPV vaccination programs. Conclusion: This review highlights the critical role of HPV vaccines in reducing the burden of HPV-related cancers, with robust efficacy, long-term protection, and favourable safety profiles. The findings underscore the need for continued research into optimised vaccination strategies and the expansion of global vaccination efforts.

HPV vaccinationhuman papillomaviruscervical cancer preventionHPV-associated cancers
ArticleOpen access2026

Efficacy and Safety of Icotrokinra (an Interleukin-23 Inhibitor) in the Management of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis

JMA Journal · vol. 9 (5) · 1397-1405

Background: Plaque psoriasis, which is a chronic immune-mediated inflammatory skin condition, significantly reduces patients' quality of life. The cytokine interleukin-23 (IL-23) is a pivotal factor in the development of psoriasis, and icotrokinra is a new oral IL-23 receptor antagonist that has shown potential effectiveness in clinical trials. The main goal of this systematic review and meta-analysis was to assess the effectiveness and safety of icotrokinra in adults and adolescents with moderate-to-severe plaque-type psoriasis. Methods: A comprehensive literature search in PubMed, ScienceDirect, and the Cochrane Library, conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards, identified randomized controlled trials that evaluated daily oral icotrokinra 200 mg versus placebo. The primary outcomes were Psoriasis Area and Severity Index (PASI) 90, Investigator's Global Assessment (IGA) 0/1, and adverse events (AEs) at 16 weeks. Risk ratios with 95% confidence intervals were summed up through a random-effects model. Results: A total of five randomized controlled trials involving 2,755 participants were included. Icotrokinra showed a significant increase in PASI 90, IGA 0/1, IGA 0, and Psoriasis Symptoms and Signs Diary 0 responses compared to placebo. The overall frequency of AEs was similar in both groups, but the rate of treatment discontinuation due to AEs was lower with icotrokinra. Conclusions: Icotrokinra is an effective and well-tolerated oral treatment for moderate-to-severe plaque psoriasis with considerable clinical and patient-reported benefits.

IL-23 inhibitorsplaque psoriasismoderate-to-severe psoriasisefficacy
ArticleOpen access20258citation· Semantic Scholar

Learning Disabilities in the 21st Century: Integrating Neuroscience, Education, and Technology for Better Outcomes

SAGE Open · vol. 15 (3)

Learning disabilities (LD) present substantial challenges for both affected individuals and society, often going under-recognized, leading to delays in diagnosis and inadequate interventions. These conditions are complex and caused by a mix of genetics, environment, and brain function. This can affect the sensory and mental information during processing, making learning more difficult. A systematic review of 19 selected studies was conducted using databases such as PubMed, Embase, Cochrane Library, and Web of Science. Studies were evaluated for risk of bias, and findings were synthesized to offer an integrated understanding of the etiology, pathophysiology, diagnostic complexities, and treatment strategies associated with LD. Key genetic and environmental risk factors were identified, and diagnostic challenges were explored, with an emphasis on the role of neurocognitive assessments and educational tools for accurate identification. The effectiveness of different treatments, such as educational programs, cognitive therapy, and novel technologies, was also assessed in terms of how well they help improve learning outcomes. The information processing theory was examined in depth, illustrating how disruptions in the processing of sensory and cognitive stimuli contribute to the learning difficulties observed in LD. The review also emphasizes the need for a team effort, bringing together parents, teachers, healthcare workers, and communities. This might provide vital support for people with LD. Advances in educational technology and cognitive training offer promising avenues for improving information processing and, consequently, educational outcomes. A holistic approach to diagnosis and intervention is essential for optimizing the quality of life and educational success of individuals with LD.

learning disabilitiesetiologygenetic risk factorsenvironmental risk factors
ArticleClosed2024

PREVALENCE OF HYPERURICEMIA AND GOUT AND THEIR RELATIONSHIP TO CERTAIN RISK FACTORS: A SYSTEMATIC REVIEW

Indian Journal Of Applied Research · 1-5

Background/ objectives: The frequency of related comorbidities, all-cause mortality, and societal costs are all on the rise, and so is the burden of gout and hyperuricemia globally. This systematic review aims to investigate the recently published literature on the prevalence and risk factors of gout and hyperuricemia. PubMed, Web of S Methods: cience, Science Direct, and Cochrane Library were systematically searched to include the relevant literature. Rayyan QRCI was used throughout this systematic approach. Results: Our results included eleven studies with a total of 204,759,079 patients diagnosed with gout and/ or hyperuricemia. The reported total prevalence of hyperuricemia was 40,169,245 (19.6%), and the prevalence of gout was 6,192,105 (3.02%). The included studies recorded a rising incidence of gout and hyperuricemia. Gout is thus an increasing problem over the world, and to addr Conclusion: ess and improve widespread poor care, international cooperation efforts are needed. Hyperuricemia and gout affected males more than females. Older age, obesity, male gender, less activity, a diet heavy in purines, and lower educational levels all had an impact on blood UA concentration. These are high-risk populations that need to have their UA levels regularly checked.

hyperuricemiagoutprevalencerisk factors